National Alzheimer's Coordinating Center
National Alzheimer's Coordinating Center
The NIA Alzheimer’s Disease Research Centers Program
National Alzheimer’s Coordinating Center

NACC references

Following are the references cited in NACC forms and related documentation.

Uniform Data Set v3

  • Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzhemers Dement, 7(3):270-279, 2011. DOI: 10.1016/j.jalz.2011.03.008
  • Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18):1789-1799, 2007. DOI: 10.1212/01.WNL.0000287431.88658.8b
  • Armstrong, MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology, 80(5):496-503, 2013. DOI: 10.1212/WNL.0b013e31827f0fd1
  • Benison G, Ludolph A, Agid Y, et al. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain, 132(Pt 1):156-171, 2009. DOI: 10.1093/brain/awn291
  • Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 1(5):293-299, 2000. DOI: 10.1080/146608200300079536
  • Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord, 13(S3):2–23, 1998. DOI: 10.1002/mds.870131303
  • Ferman TJ, Boeve BF, Smith GE, et al. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology, 77(9):875-882, 2011. DOI: 10.1212/WNL.0b013e31822c9148
  • Ferman TJ, Smith GE, Boeve BF, et al. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer’s disease. Clin Neuropsychol, 20(4):623-636, 2006. DOI: 10.1080/13854040500376831
  • Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia, 55(4):475-482, 2014. DOI: 10.1111/epi.12550
  • Roman GC, Erkinjuntti T, Wallin A, et al. Subcortical ischaemic vascular dementia. Lancet Neurol, 1(7):426-436, 2002. DOI: 10.1016/S1474-4422(02)00190-4
  • Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology, 71(9):670-676, 2008. DOI: 10.1212/01.wnl.0000324625.00404.15
  • Ivanova I, Salmon DP, Gollan TH. The multilingual naming test in Alzheimer's disease: clues to the origin of naming impairments. J Int Neuropsychol Soc, 19(3):272-283, 2013. DOI: 10.1017/S1355617712001282
  • Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord, 18(5):467-486, 2003. DOI: 10.1002/mds.10459
  • Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke, 27(8):1274-1282, 1996. DOI: 10.1161/01.STR.27.8.1274
  • McKee AC, Cantu RC, Nowinski CJ, et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol, 68(7):709-735, 2009. DOI: 10.1097/NEN.0b013e3181a9d503
  • McKeith IF, Ferman TJ, Thomas AJ, et al. Research criteria for the dianosis of prodromal dementia with Lewy bodies, Neurology 2020; 94: 1-13
  • McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and Management of Dementia with Lewy Bodies: Third report of the DLB Consortium. Neurology, 65(12):1863-1872, 2005. DOI: 10.1212/01.wnl.0000187889.17253.b1
  • McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement, 7(3):263-269, 2011. DOI: 10.1016/j.jalz.2011.03.005
  • Menon DK, Schwab K, Wright DW, et al. Position statement: definition of traumatic brain injury. Arch Phys Med Rehabil, 91(11):1637-1640, 2010. DOI: 10.1016/j.apmr.2010.05.017
  • Morris JC. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43(11):2412-2414, 1993. DOI: 10.1212/WNL.43.11.2412-a
  • Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc, 53(4):695-699, 2005. DOI: 10.1111/j.1532-5415.2005.53221.x
  • Pfeffer RI, Kurosaki TT, Harrah CH, et al. Measurements of functional activities of older adults in the community. J Gerontol, 37(3):323-329, 1982. DOI: 10.1093/geronj/37.3.323
  • Possin KL, Laluz VR, Alcantar OZ, et al. Distinct neuroanatomical substrates and cognitive mechanisms of figure copy performance in Alzheimer's disease and behavioral variant frontotemporal dementia. Neuropsychologia, 49(1):43-48, 2011. DOI: 10.1016/j.neuropsychologia.2010.10.026
  • Puoti G1, Bizzi A, Forloni G, et al. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol, 11(7):618-628, 2012. DOI: 10.1016/S1474-4422(12)70063-7
  • Crutch SJ, Schott JM, Rabinovici GD, et al. Shining a light on posterior cortical atrophy. Alzheimers Dement, 9(4):463-465, 2013. DOI: 10.1016/j.jalz.2012.11.004
  • Rossetti HC, Lacritz LH, Cullum CM, et al. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology; 77(13):1272-1275, 2011. DOI: 10.1212/WNL.0b013e318230208a
  • Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clinical Gerontology: A Guide to Assessment and Intervention 165–173, NY: The Haworth Press, 1986.
  • Shirk SD, Mitchell MB, Shaughnessy LW, et al. A web-based normative calculator for the Uniform Data Set (UDS) neuropsychological test battery. Alzheimers Res Ther, 3(6):32, 2011. DOI: 10.1186/alzrt94
  • Stern RA, Daneshvar DH, Baugh CM, et al. Clinical presentation of chronic traumatic encephalopathy. Neurology, 81(13):1122-1129, 2013. DOI: 10.1212/WNL.0b013e3182a55f7f
  • Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol, 12(8):822-838, 2013. DOI: 10.1016/S1474-4422(13)70124-8
  • Weintraub S, Salmon D, Mercaldo N, et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychological test battery. Alzheimer Dis Assoc Disord, 23(2):91-101, 2009. DOI: 10.1097/WAD.0b013e318191c7dd

Uniform Data Set v2.0

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
  • Aho K, Harmsen P, Hatano S, et al. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ, 58(1):113-130, 1980. PMCID: PMC2395897
  • Beekly DL, Ramos EM, Lee WW, et al. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord, 21(3):249-258, 2007. DOI: 10.1097/WAD.0b013e318142774e
  • Fahn S, Elton R. UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S MC, Calne DB, Goldstein M, ed. Recent developments in Parkinson's disease. Vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163, 293-304.
  • Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. 2nd ed. Philadelphia: Lea and Febiger, PRO-ED Inc; 1983.
  • Kukull WA, Larson EB, Teri L, et al. The Mini-Mental State Examination score and the clinical diagnosis of dementia. J Clin Epidemiol, 47(9):1061-1067, 1994. DOI: 10.1016/0895-4356(94)90122-8
  • Kumar R, Bergeron C, Pollanen M, Lang A. Cortical basal ganglionic degeneration. In: Jankovic J TE, ed. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins; 1998:297-316.
  • Lang A, Riley D, Bergeron C. Cortico-basal ganglionic degeneration. In: DB C, ed. Neurodegenerative diseases. Philadelphia: WB Saunders; 1994:877-894.
  • Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology, 47(1):1-9, 1996. DOI: 10.1212/WNL.47.1.1
  • McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34(7):939-944, 1984. DOI: 10.1212/WNL.34.7.939
  • Mesulam MM. Primary progressive aphasia. Ann Neurol, 49(4):425-432, 2001. DOI: 10.1002/ana.91
  • Mesulam MM. Primary progressive aphasia--a language-based dementia. N Engl J Med, 349(16):1535-1542, 2003. DOI: 10.1056/NEJMra022435
  • Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord, 20(4):210-216, 2006. DOI: 10.1097/01.wad.0000213865.09806.92
  • Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneratio: a consensus on clinical diagnostic criteria. Neurology, 51(6):1546-1554, 1998. DOI: 10.1212/WNL.51.6.1546
  • Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol, 62(7):1160-1163, 2005. DOI: 10.1001/archneur.62.7.1160
  • Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43(2):250-260, 1993.
  • Rosen WG, Terry RD, Fuld PA, et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol, 7(5):486-488, 1980. DOI: 10.1002/ana.410070516

FTLD Module

  • Carver CS, White TL, Teri L. Behavioral inhibition, behavioral activation, and effective responses to impending reward and punishment: The BIS/BAS Scales. J Pers Soc Psychol, 67(2):319-333, 1994.
    PDF
  • Lennox RD, Wolfe, RN. Revision of the Self-Monitoring Scale. J Pers Socl Psychol, 46(6):1349-1364, 1984. DOI: 10.1037/0022-3514.46.6.1349
  • Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology, 80(5):496-503, 2013. DOI: 10.1212/WNL.0b013e31827f0fd1
  • Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 1(5):293-299, 2000. DOI: 10.1080/146608200300079536
  • Davis M. Measuring individual differences in empathy: evidence for a multidimensional approach. J Pers Soc Psychol, 44(1):113-126, 1983. DOI: 10.1037/0022-3514.44.1.113
  • Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology, 76(11):1006-1014, 2011. DOI: 10.1212/WNL.0b013e31821103e6
  • Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord, 18(5):467-486, 2003. DOI: 10.1002/mds.10459
  • Mesulam MM. Primary progressive aphasia--a language-based dementia. N Engl J Med, 349(16):1535-1542, 2003. DOI: 10.1056/NEJMra022435
  • Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134(9):2456-2477, 2011. DOI: 10.1093/brain/awr179
  • Rogalsky C, Love T, Driscoll D, et al. Are mirror neurons the basis of speech perception? Evidence from five cases with damage to the purported human mirror system. Neurocase, 17(2):178-187, 2011. DOI: 10.1080/13554794.2010.509318
  • Thompson CK, Lukic S, King MC, et al. Verb and noun deficits in stroke-induced and primary progressive aphasia: The Northwestern Naming Battery(). Aphasiology, 26(5):632-655, 2012. DOI: 10.1080/02687038.2012.676852
  • Weintraub S, Mesulam MM, Wieneke C, et al. The northwestern anagram test: measuring sentence production in primary progressive aphasia. Am J Alzheimers Dis Other Demen, 24(5):408-416, 2009. DOI: 10.1177/1533317509343104

LBD Module

  • Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging- Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease, 270-279, 2011.
  • Armstrong MJ, Litvan I, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80; 496.
  • Boeve BF, Molano JR, Ferman TJ, Smith GE, Lin S-C, Bieniek K, Haidar W, Tippmann-Peikert M, Knopman DS, Graff-Radford NR, Lucas JA, Petersen RC, Silber MH. Validation of the Mayo Sleep Questionnaire to Screen for REM Sleep Behavior Disorder in an Aging and Dementia Cohort. Sleep Med. 2011 May; 12(5): 445-453.
  • Brooks BR, Miller RG, Swash M, Munsat TL, Diseases WFoNRGoMN. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 200;1(5): 293-299.
  • Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gorbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994: 2308-2314
  • Cummings JL. The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology 1997; 48 (Suppl. 6): S10-S16
  • Fahn S, Elton RL, UPDRS Development Committee. The Unified Parkinson’s Disease Rating Scale. In Fahn S, Marsden CD, Caline DB, Goldstein M, eds. Recent developments in Parkinson’s diseases, Vol. 2. Florham Park, NJ: Macmillan Healthcare Information, 1987: 153-163, 293-304.
  • Ferman TJ, Smith GE, Boeve RJ, Ivnik RJ, Petersen RC, Knopman D, Graff-Radford N, Parisi J, Dickson DW. DLB fluctuations: Specific features that reliably differentiate DLB from AD and normal aging. Neurology; 62(2):181-187.
  • Hoehn MM, Yahr MD (1967): Parkinsonism: onset, progression and mortality. Neurology, 17: 427-442
  • Kaufer DI, Cummings JL, Christine D, Bray T, Castellon S, Masterman D, MacMillan A, Ketchel P, Dekosky ST. Assessing the impact of neuropsychiatric symptoms in Alzheimer’s disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatric Soc 1998; 46: 210-215.
  • Lance JW, Schwab RS, Peterson EA (1963) Action tremor and the cogwheel phenomenon in Parkinson's disease. Brain, 86:95-110.
  • Litvan I, Ghatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord, 18(5): 467-486, 2003. DOI: 10.1002/mds. 10459
  • Mamiya Y, Nishio Y, Watanabe H, Yokoi K, Uchiyama M, Baba T, et al. (2016) The Pareidolia Test: A Simple Neuropsychological Test Measuring Visual Hallucination-like Illusions. PLoS ONE 11(5):e0154713. https://doi.org/10.1371/journal.pone.0154713
  • Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM. Assessment of Sleep and Sleepiness in Parkinson Disease. SLEEP 2003; 26(8): 1049-1054.
  • McKeith IF, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium, Neurology 2017; 89: 88-100.
  • McKeith IF, Ferman TJ, Thomas AJ, et al. Research criteria for the dianosis of prodromal dementia with Lewy bodies, Neurology 2020; 94: 1-13
  • McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging- Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 2011; 7(3):263-269.
  • Mesulam MM. 2003. Primary progressive aphasia: A language-based dementia. New England Journal of Medicine 348. 1535-1542.
  • Wood S, Cummings JL, Hsu M-A, Barclay T, Wheatley MV, Yarema KT, Schnelle JF. The use of the Neuropsychiatric Inventory in nursing home residents: characterization and measurement. Am J Geriatr Psychiatry 1999; 8:75-83.

Neuropathology Data Set

  • Alafuzoff I, Thal DR, Arzberger T, et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol, 117(3):309-320, 2009. DOI: 10.1007/s00401-009-0485-4
  • Bigio EH, Lipton AM, Yen SH, et al. Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. J Neuropathol Exp Neurol, 60(4):328-341, 2001. DOI: 10.1093/jnen/60.4.328
  • Cairns NJ, Neumann M, Bigio EH, et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol, 171(1):227-240, 2007. DOI: 10.2353/ajpath.2007.070182
  • Dickson DW. Pick's disease: a modern approach. Brain Patho, 8(2):339-354, 1998. DOI: 10.1111/j.1750-3639.1998.tb00158.x
  • Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol, 246(S2):II6-15, 1999. DOI: 10.1007/BF03161076
  • Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol, 61(11):935-946, 2002. DOI: 10.1093/jnen/61.11.935
  • Hyman BT, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement, (1):1-13, 2012. DOI: 10.1016/j.jalz.2011.10.007
  • Kovacs GG, Majtenyi K, Spina S, et al. White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol, 67(10):963-975, 2008. DOI: 10.1097/NEN.0b013e318187a80f
  • Mackenzie IR, Munoz DG, Kusaka H, et al. Distinct pathological subtypes of FTLD-FUS. Acta Neuropathol, 121(2):207-218, 2011. DOI: 10.1007/s00401-010-0764-0
  • Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneratio: an update. Acta Neuropathol. 2010;119(1):1-4. . DOI: 10.1007/s00401-009-0612-2
  • McKee AC, Stein TD, Nowinski CJ, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain, 136(Pt 1):43-64, 2013. DOI: 10.1093/brain/aws307
  • McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology, 65(12):1863-1872, 2005. DOI: 10.1212/01.wnl.0000187889.17253.b1
  • Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med, 117(2):132-144, 1993.
  • Montine TJ, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol, 123(1):1-11, 2012. DOI: 10.1007/s00401-011-0910-3
  • Olichney JM, Hansen LA, Hofstetter CR, et al. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch Neurol, 57(6):869-874, 2000. DOI: 10.1001/archneur.57.6.869
  • Thal DR, Rüb U, Orantes M, et al. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology, 58(12):1791-1800, 2002. DOI: 10.1212/WNL.58.12.1791
  • Vonsattel JP, Myers RH, Hedley-Whyte ET, et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol, 30(5):637-649, 1991. DOI: 10.1002/ana.410300503